K193522

Substantially Equivalent

iMedium Single Step; iMedium Single Step with HSA; iMedium Single Step with rHA

Applicant: Kitazato Corporation
Product code: MQL
Advisory panel: Obstetrics/Gynecology
Date received: 2019-12-19
Decision date: 2020-08-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Fuji-Shi, JP

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.